Since its establishment in 1992, Dongying Tiandong Pharmaceutical Co.,Ltd has committed to the development of special products in blood field and polysaccharide series. Relying on the powerful backing of Haike group, adhering to the spirit of learning and innovation, increasing investment in research and development, Dongying Tiandong possesses research and development platform including one biochemical drugs engineering Laboratory of Shandong province and a Post-Doctoral Research Center, and has undertaken the national major scientific research projects such as “Significant New Drugs Development”and “Key Technology R&D Program”. The company has participated in the quality specification establishment of 5 kinds of domestic low molecular weight heparins and obtained 18 patents, and it makes important contribution to industrialization and quality improvement of domestic low molecular weight heparin. With increasingly strict supervision of global regulatory, the company pays more attention to the traceability of the main raw material-crude heparin. It has now its own crude heparin production base, and activates site inspection for all its approved crude heparin suppliers which have all approved by US FDA and got EIR. The company has strictest quality traceability system, which fully ensures the controllability and traceability of the source of crude heparin. The main marketing products now are heparin related products such as Heparin sodium, Enoxaparin sodium, Dalteparin sodium and Nadroparin Calcium etc. Meanwhile, the company is aggressively developing new products such as sulodexide, Ferric carboxymaltose, and mucoplysaccharide polysulfate cream etc to expand the products range and focus on more drugs application area. For more than 20 years, we have been committed to providing the world with better drugs and services, and gradually establish a complete drug management system through continuous innovation, research and development.
